Table 1:

Recommendations for next steps in incorporating GA in research. Dr. Hurria significantly contributed to these recommendations

ASCO 2015 Workshop	ASCO-FDA Workshop	ASCO 2019 Research Priorities
NCI, FDA, and other organizations should advocate for collection of GA domains in trials	Design more trials including elements of GA and endpoints important to older adults	Use GA as standard measure of aging physiology to reliably predict treatment side-effects
Research and clinical databases should include GA domains in their variables measured	GA should be routinely collected and documented in EHRs	Study the impact of cancer treatment on GA domains, such as cognition and function
	Database developers should partner with EHR vendors to incorporate GA domains	Study the effects of cancer treatment on older adults with impaired GA domains
		Conduct trials studying effects of GA-guided care

ASCO = American Society of Clinical Oncology; NCI = National Cancer Institute; FDA = Food and Drug Administration; EHR = Electronic Health Record